Australia's most trusted source of pharma news
Friday, 20 July 2018
Lost Your Access?
D-Day nears in Pfizer PBS case
Hearings end, judgment reserved, court seals evidence.
Meds bodies try to rebuild trust
Join initiative aimed at increasing public faith in business.
MA in turmoil as Cook quits
Staff gagged over reasons for chair's sudden exit.
Eight pharmas in ATO sights
Multiple investigations focussed on transfer pricing.
Security threat to Aust trials
Researchers say new law could wreck multisite trials.
UK votes to remain in EMA
Backs trying to stay following Brexit
Ex-Pfizer boss' punt pays off
Revived 1970s drug gets FDA fast-track review.
Pfizer remake to star Aust talent
Former Aussie MD scores top global biosim job in restructure.
Italian major sets up in Aust
One of the Euro nation's top ten opens Sydney office.
J&J to fight huge damages bill
Multi-billion dollar award the result of 'unfair process'.
Big moves in comms jobs
Four senior roles to fill and two new appointments.
MA plots 'strategic direction'
Board, advisory council meet to assess future prospects.
TGA slaps warning on SGLT2s
Spike in local reports sparks serious action.
Bayer fights back with Xarelto
Anticoagulant makers wield competing study results.
PBAC reject drives J&J growth
Darzalex is leading global growth - but not in Aust.
Novartis stretches class lead
Kisqali expanded to premenopausal women.
Why Sunday is 'Good News' for Hunt
How the Minister for Saving Lives is making the most of the sabbath.
Gilead's HIV drug approved
Reimbursement likely to follow.
Events & Conferences
Â© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design